Medtronic Taps Into Expanded Spinal Market With $3.9 Billion Kyphon Deal
This article was originally published in The Gray Sheet
Medtronic is aiming to expand the breadth of its spinal offerings and, in particular, reach a relatively untapped older patient population with its $3.9 billion acquisition of Kyphon, announced July 27 (see chart: "1Medtronic-Kyphon Deal Basics")
You may also be interested in...
The firm says the new system will give physicians more options to treat patients with a varying severity of spinal injury.
Benvenue Medical Inc. announced the launch of its Kiva VCF Treatment System for vertebral compression fractures in the spine March 24, along with favorable data announced at a meeting of the Society of Interventional Radiology.
Patent attorneys suggest lawsuits from firms that buy up device patents purely to pursue litigation, which appears to have occurred recently with Medtronic’s kyphoplasty patents, may become a more common occurrence.